These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37511673)

  • 1. Precision Medicine for More Oxygen (P4O2)-Study Design and First Results of the Long COVID-19 Extension.
    Baalbaki N; Blankestijn JM; Abdel-Aziz MI; de Backer J; Bazdar S; Beekers I; Beijers RJHCG; van den Bergh JP; Bloemsma LD; Bogaard HJ; van Bragt JJMH; van den Brink V; Charbonnier JP; Cornelissen MEB; Dagelet Y; Davies EH; van der Does AM; Downward GS; van Drunen CM; Gach D; Geelhoed JJM; Glastra J; Golebski K; Heijink IH; Holtjer JCS; Holverda S; Houweling L; Jacobs JJL; Jonker R; Kos R; Langen RCJ; van der Lee I; Leliveld A; Mohamed Hoesein FAA; Neerincx AH; Noij L; Olsson J; van de Pol M; Pouwels SD; Rolink E; Rutgers M; Șahin H; Schaminee D; Schols AMWJ; Schuurman L; Slingers G; Smeenk O; Sondermeijer B; Skipp PJ; Tamarit M; Verkouter I; Vermeulen R; de Vries R; Weersink EJM; van de Werken M; de Wit-van Wijck Y; Young S; Nossent EJ; Maitland-van der Zee AH;
    J Pers Med; 2023 Jun; 13(7):. PubMed ID: 37511673
    [No Abstract]   [Full Text] [Related]  

  • 2. Long COVID exhibits clinically distinct phenotypes at 3-6 months post-SARS-CoV-2 infection: results from the P4O2 consortium.
    Blankestijn JM; Abdel-Aziz MI; Baalbaki N; Bazdar S; Beekers I; Beijers RJHCG; Bloemsma LD; Cornelissen MEB; Gach D; Houweling L; Holverda S; Jacobs JJL; Jonker R; van der Lee I; Linders PMA; Mohamed Hoesein FAA; Noij LCE; Nossent EJ; van de Pol MA; Schaminee DW; Schols AMWJ; Schuurman LT; Sondermeijer B; Geelhoed JJM; van den Bergh JP; Weersink EJM; de Wit-van Wijck Y; Maitland-van der Zee AH;
    BMJ Open Respir Res; 2024 Apr; 11(1):. PubMed ID: 38663887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary function 3-6 months after acute COVID-19: A systematic review and multicentre cohort study.
    Cornelissen MEB; Leliveld A; Baalbaki N; Gach D; van der Lee I; Nossent EJ; Bloemsma LD; Maitland-van der Zee AH
    Heliyon; 2024 Mar; 10(6):e27964. PubMed ID: 38533004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case-control study.
    Fernández-de-Las-Peñas C; Gómez-Mayordomo V; Cuadrado ML; Palacios-Ceña D; Florencio LL; Guerrero AL; García-Azorín D; Hernández-Barrera V; Arendt-Nielsen L
    Cephalalgia; 2021 Nov; 41(13):1332-1341. PubMed ID: 34134526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial.
    Saiz-Rodríguez M; Peña T; Lázaro L; González Á; Martínez A; Cordero JA; Vicente JT; Richard F; Coma MJ; de Frutos M; Labrador J; Pueyo A
    Trials; 2020 Jul; 21(1):632. PubMed ID: 32646502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole blood transcriptome in long-COVID patients reveals association with lung function and immune response.
    Blankestijn JM; Baalbaki N; Bazdar S; Beekers I; Beijers RJHCG; van den Bergh JP; Bloemsma LD; Cornelissen MEB; Dekker T; Duitman JW; Houweling L; Jacobs JJL; van der Lee I; Linders PMA; Noij LCE; Nossent EJ; van de Pol MA; Sondermeijer BM; Geelhoed JJM; Weersink EJM; Golebski K; Abdel-Aziz MI; Maitland-van der Zee AH;
    J Allergy Clin Immunol; 2024 Sep; 154(3):807-818. PubMed ID: 38830512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating phenotypes of pulmonary COVID-19 recovery: A longitudinal observational prospective multicenter trial.
    Sonnweber T; Tymoszuk P; Sahanic S; Boehm A; Pizzini A; Luger A; Schwabl C; Nairz M; Grubwieser P; Kurz K; Koppelstätter S; Aichner M; Puchner B; Egger A; Hoermann G; Wöll E; Weiss G; Widmann G; Tancevski I; Löffler-Ragg J
    Elife; 2022 Feb; 11():. PubMed ID: 35131031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period.
    Dagher H; Chaftari AM; Subbiah IM; Malek AE; Jiang Y; Lamie P; Granwehr B; John T; Yepez E; Borjan J; Reyes-Gibby C; Flores M; Khawaja F; Pande M; Ali N; Rojo R; Karp DD; Chaftari P; Hachem R; Raad II
    Elife; 2023 Feb; 12():. PubMed ID: 36748905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19.
    Taquet M; Dercon Q; Luciano S; Geddes JR; Husain M; Harrison PJ
    PLoS Med; 2021 Sep; 18(9):e1003773. PubMed ID: 34582441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-COVID condition in patients with inflammatory rheumatic diseases: a prospective cohort study in the Netherlands.
    Boekel L; Atiqi S; Leeuw M; Hooijberg F; Besten YR; Wartena R; Steenhuis M; Vogelzang E; Webers C; Boonen A; Gerritsen M; Lems WF; Tas SW; van Vollenhoven RF; Voskuyl AE; van der Horst-Bruinsma I; Nurmohamed M; Rispens T; Wolbink G
    Lancet Rheumatol; 2023 Jul; 5(7):e375-e385. PubMed ID: 37398978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post COVID-19 condition after delta infection and omicron reinfection in children and adolescents.
    Ertesvåg NU; Iversen A; Blomberg B; Özgümüş T; Rijal P; Fjelltveit EB; Cox RJ; Langeland N;
    EBioMedicine; 2023 Jun; 92():104599. PubMed ID: 37149931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society.
    Zatloukal J; Brat K; Neumannova K; Volakova E; Hejduk K; Kocova E; Kudela O; Kopecky M; Plutinsky M; Koblizek V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Dec; 164(4):325-356. PubMed ID: 33325455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outpatient Pulmonary Rehabilitation in Patients with Long COVID Improves Exercise Capacity, Functional Status, Dyspnea, Fatigue, and Quality of Life.
    Nopp S; Moik F; Klok FA; Gattinger D; Petrovic M; Vonbank K; Koczulla AR; Ay C; Zwick RH
    Respiration; 2022; 101(6):593-601. PubMed ID: 35203084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.